Alzheimer's Disease Blood-Based Biomarkers: A Clinical and Laboratory Perspective
Tracking # 20-1263194
Price not reported
There are no ratings for this course
Learn moreCourse overview
This webinar is for laboratorians, clinicians, and other stakeholders interested in learning about Alzheimer's Disease, the new anti-amyloid FDA approved therapies, and the use of blood-based biomarkers in the patient journey, especially their role in diagnosing early-stage Alzheimer's disease. This webinar will offer a clinician's perspective on the importance of these novel diagnostic tools in detecting amyloid pathology in individuals presenting with cognitive impairment and how they can be integrated into clinical practice, as well as a clinical laboratory perspective on Alzheimer's biomarker implementation. This activity is meant to offer insights into the best practices to incorporate blood-based biomarker tests in the standard of care for patients suspected of Alzheimer's disease.
Subject areas
This course counts toward the state boards and subject areas below.
American Board of Clinical Chemistry
Clinical Chemistry Diplomate
Molecular Diagnostics Diplomate
Toxicological Chemistry Diplomate
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technologist
Disclosure statements
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Alicia Algeciras-Schimnich, PhD
- Honorarium/Expenses: Roche Diagnostics
- Board/Committee Membership/Advisory Board: Roche Diagnostics, Fujirebio Diagnostics
- Vijay Ramanan, MD, PhD
- Grant/Research Support: Eisai, Transposon Therapeutics, Inc.